[go: up one dir, main page]

ZA200307307B - Amphotericin B aqueous composition. - Google Patents

Amphotericin B aqueous composition. Download PDF

Info

Publication number
ZA200307307B
ZA200307307B ZA200307307A ZA200307307A ZA200307307B ZA 200307307 B ZA200307307 B ZA 200307307B ZA 200307307 A ZA200307307 A ZA 200307307A ZA 200307307 A ZA200307307 A ZA 200307307A ZA 200307307 B ZA200307307 B ZA 200307307B
Authority
ZA
South Africa
Prior art keywords
phospholipids
sodium chloride
amphotericin
low toxicity
composition containing
Prior art date
Application number
ZA200307307A
Other languages
English (en)
Inventor
Srikanth Annappa Pai
Sangeeta Hanurmesh Rivankar
Original Assignee
Bharat Serums & Vaccines Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bharat Serums & Vaccines Ltd filed Critical Bharat Serums & Vaccines Ltd
Publication of ZA200307307B publication Critical patent/ZA200307307B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ZA200307307A 2001-03-01 2003-09-18 Amphotericin B aqueous composition. ZA200307307B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN217MU2001 IN188924B (fr) 2001-03-01 2001-03-01

Publications (1)

Publication Number Publication Date
ZA200307307B true ZA200307307B (en) 2004-04-20

Family

ID=11097223

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200307307A ZA200307307B (en) 2001-03-01 2003-09-18 Amphotericin B aqueous composition.

Country Status (23)

Country Link
US (1) US20040137049A1 (fr)
EP (1) EP1368041B1 (fr)
JP (1) JP2004523566A (fr)
KR (1) KR100810067B1 (fr)
CN (1) CN1255114C (fr)
AT (1) ATE274913T1 (fr)
AU (1) AU2001250643B2 (fr)
BG (1) BG108188A (fr)
BR (1) BR0116922A (fr)
CA (1) CA2438847A1 (fr)
CZ (1) CZ20032264A3 (fr)
DE (1) DE60105322T2 (fr)
DK (1) DK1368041T3 (fr)
EA (1) EA006241B1 (fr)
ES (1) ES2227172T3 (fr)
IN (1) IN188924B (fr)
MX (1) MXPA03007777A (fr)
NZ (1) NZ528281A (fr)
PT (1) PT1368041E (fr)
SK (1) SK10742003A3 (fr)
WO (1) WO2002069983A1 (fr)
YU (1) YU75403A (fr)
ZA (1) ZA200307307B (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
JP2006069929A (ja) * 2004-08-31 2006-03-16 Konica Minolta Medical & Graphic Inc 真菌症治療製剤およびその製造方法
EA200700440A1 (ru) * 2004-09-13 2008-02-28 Бхарат Сирумс Энд Вэксинс Лтд. Композиции стабильных эмульсий для внутривенного введения, имеющие защитную эффективность
WO2006083761A2 (fr) 2005-02-03 2006-08-10 Alza Corporation Solutions de solvant/polymere utilisees comme vehicules de suspension
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
US8052996B2 (en) 2005-02-03 2011-11-08 Intarcia Therapeutics, Inc. Two-piece, internal-channel osmotic delivery system flow modulator
CN100418536C (zh) * 2005-04-06 2008-09-17 河南省眼科研究所 一种用于眼科的抗真菌药物组合物
PT2359808E (pt) 2006-08-09 2013-08-28 Intarcia Therapeutics Inc Sistemas de entrega osmótica e montagens de pistão
PL2157967T3 (pl) 2007-04-23 2013-06-28 Intarcia Therapeutics Inc Formulacje zawiesinowe peptydów insulinotropowych i ich zastosowania
CA2726861C (fr) 2008-02-13 2014-05-27 Intarcia Therapeutics, Inc. Dispositifs, formulations et methodes d'administration de plusieurs agents benefiques
HUE035862T2 (en) 2009-09-28 2018-05-28 Intarcia Therapeutics Inc Rapid establishment and/or termination of substantial steady-state drug delivery
KR101629521B1 (ko) * 2010-03-16 2016-06-13 우석대학교 산학협력단 난용성 약물 가용화 및 생체막 투과증진을 위한 알코올성 수상을 내상으로 하는 리포좀, 리포좀 조성물 및 리포좀의 제조방법
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
CN102525921B (zh) * 2012-02-06 2013-08-07 西安力邦制药有限公司 2,2’,6,6’-四异丙基-4,4’-二联苯酚脂微球制剂及其制备方法
US9744191B2 (en) 2012-03-19 2017-08-29 Yale University Antimicrobial compositions and methods
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
MX2017015504A (es) 2015-06-03 2018-05-15 Intarcia Therapeutics Inc Sistemas de colocacion y remoción de implante.
EP3222324B1 (fr) * 2016-03-23 2020-05-13 Wayne State University Valproate en tant que traitement antifongique topique
CA3024479A1 (fr) 2016-05-16 2017-11-23 Intarcia Therapeutics, Inc. Polypeptides selectifs du recepteur du glucagon et methodes pour les employer
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
CN110225762A (zh) 2017-01-03 2019-09-10 因塔西亚制药公司 包括glp-1受体激动剂的连续施用和药物的共同施用的方法
CN108344811A (zh) * 2017-01-24 2018-07-31 北京泰德制药股份有限公司 一种注射用脂质体中有机溶剂残留的检测方法
CN108309955B (zh) * 2018-04-27 2020-06-02 武昌理工学院 一种聚明胶肽结合型紫杉醇纳米颗粒的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1338736C (fr) * 1986-12-05 1996-11-26 Roger Baurain Microcristaux comportant une substance active presentant une affinite pour les phospholipides, et au moins un phospholipide, procede de preparation
US5616334A (en) * 1987-03-05 1997-04-01 The Liposome Company, Inc. Low toxicity drug-lipid systems
US5100662A (en) * 1989-08-23 1992-03-31 The Liposome Company, Inc. Steroidal liposomes exhibiting enhanced stability
FR2651680B1 (fr) * 1989-09-14 1991-12-27 Medgenix Group Sa Nouveau procede de preparation de microparticules lipidiques.
US5580575A (en) * 1989-12-22 1996-12-03 Imarx Pharmaceutical Corp. Therapeutic drug delivery systems
JP3956402B2 (ja) * 1996-03-04 2007-08-08 日本油脂株式会社 アンホテリシンｂ運搬体
US6180136B1 (en) * 1998-11-10 2001-01-30 Idexx Laboratories, Inc. Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use

Also Published As

Publication number Publication date
BR0116922A (pt) 2004-04-27
CZ20032264A3 (cs) 2003-12-17
CA2438847A1 (fr) 2002-09-12
NZ528281A (en) 2006-11-30
ES2227172T3 (es) 2005-04-01
KR100810067B1 (ko) 2008-03-05
EP1368041B1 (fr) 2004-09-01
DK1368041T3 (da) 2005-01-17
EA006241B1 (ru) 2005-10-27
IN188924B (fr) 2002-11-23
EP1368041A1 (fr) 2003-12-10
EA200300948A1 (ru) 2004-04-29
AU2001250643B2 (en) 2007-03-22
CN1505519A (zh) 2004-06-16
BG108188A (bg) 2004-09-30
YU75403A (sh) 2006-05-25
PT1368041E (pt) 2005-01-31
CN1255114C (zh) 2006-05-10
MXPA03007777A (es) 2003-12-08
WO2002069983A1 (fr) 2002-09-12
KR20040018337A (ko) 2004-03-03
DE60105322T2 (de) 2005-09-15
US20040137049A1 (en) 2004-07-15
JP2004523566A (ja) 2004-08-05
ATE274913T1 (de) 2004-09-15
SK10742003A3 (sk) 2004-01-08
DE60105322D1 (de) 2004-10-07

Similar Documents

Publication Publication Date Title
EP1368041B1 (fr) Composition aqueuse d'amphoterocine b
AU2001250643A1 (en) Amphotericin B aqueous composition
EP0295248B2 (fr) Preparation antibiotique a base de liposomes
EP1389089B1 (fr) Methode et composition permettant de solubiliser un compose biologiquement actif a faible solubilite dans l'eau
EP0380584B1 (fr) Poudres pre-liposomiques de macrolide de polyene
JPH11507369A (ja) プレリポソーム凍結乾燥体から得られるサブミクロンリポソーム懸濁液
WO2004017940A2 (fr) Preparations de sn38 pharmaceutiquement active a base de lipides
NO174833B (no) Fremgangsmåte for fremstilling av et injiserbart preparat
CN101385715B (zh) 一种难溶性药物脂质体制备方法
CN101530393B (zh) 一种克林霉素磷酸酯脂质体冻干制剂
EP2656849A1 (fr) Liposome comprenant une combinaison de chloroquine et d'adriamycine et procédé de préparation associé
CN101766571B (zh) 一种头孢匹胺/苯甲酸钠/碳酸氢钠药物组合物脂质体注射剂
CN102188378A (zh) 包载水溶性药物脂质体的制备方法
US20060030578A1 (en) Pharmaceutically active lipid based formulation of irinotecan
US20090011001A1 (en) Manufacturing process for liposomal preparations
WO2003018018A2 (fr) Compositions de vinorelbine et methodes d'utilisation
CN102327222B (zh) 一种盐酸托烷司琼脂质体注射剂
ZA200300330B (en) Amphotericin B Structured emulsion.
KR100832553B1 (ko) 암포테리신 β를 봉입하고 표면이 헤파린으로 수식된지질나노입자 및 이의 제조방법
AU641532B2 (en) Liposome preparation and antibiotic
Sautereau et al. Inhibition of tumor cell growth in vitro and in vivo by 2‐methyl 9‐hydroxyellipticinium entrapped within phospholipid vesicles
CN115137702A (zh) 人参皂苷高三尖杉酯碱脂质体、其制备方法和应用
MXPA97005592A (en) Pharmaceutical compositions containing corticosteroids and preparation of mys